Peter Libby

In December 2014, Peter Libby, MD, world-renowned KOL in the field of cardiology, joined Olatec’s Scientific Advisory Board and Drug Development Team. For Olatec, Dr. Libby is focusing his efforts on conducting in vivo studies seeking to establish the Lead Compound’s ability to treat cardiovascular disease. Dr. Libby was the Chief of Cardiovascular Medicine at Brigham and Women’s Hospital in Boston, Massachusetts for over 15 years. He also serves as the Mallinckrodt Professor of Medicine at Harvard Medical School. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has received numerous awards and recognitions for his accomplishments, most recently including the Gold Medal of the European Society of Cardiology (2011), the Basic Research Prize of the American Heart Association (2011), Award for Lifetime Achievements in Cardiology from the Austrian Society of Cardiology (2012), Anitschkow Prize in Atherosclerosis Research from the European Atherosclerosis Society (2013), the Lifetime Achievement Award from the Heart Failure Association of the European Society of Cardiology (2014), and the Jung Foundation Gold Medal for Medicine in 2016. His areas of clinical expertise include general and preventive cardiology. Dr. Libby’s professional memberships include the Association of American Physicians, the American Society for Clinical Investigation, and elected honorary memberships in the British Atherosclerosis Society, the Japan Circulation Society, and the Japanese College of Cardiology. He has served as the President of the Association of University Cardiologists. He also has served in many roles as a volunteer for the American Heart Association, including chairman of several research committees and member of the executive committees of the Councils on Arteriosclerosis, Circulation, and Basic Science. He has served two terms as Chairperson of the American College of Cardiology’s Research Allocations Peer Review Committee. He directed the DW Reynolds Cardiovascular Clinical Research Center and two cycles of Leducq Foundation Awards, and has received continuous funding from the National Heart, Lung, and Blood Institute for several decades. An author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published extensively in medical journals including Circulation, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, New England Journal of Medicine, and Nature. He is one of the Editors of Braunwald’s Heart Disease, having served as the Editor-in Chief of the 8th Edition. Dr. Libby has also contributed chapters on the pathogenesis, treatment, and prevention of atherosclerosis to Harrison’s Principles of Internal Medicine. He has held numerous visiting professorships and has been selected to deliver some 90 named or keynote lectures throughout the world. Dr. Libby earned his medical degree at the University of California, San Diego, and completed his training in internal medicine and cardiology at the Peter Bent Brigham Hospital (now Brigham and Women’s Hospital). He also holds an honorary MA degree from Harvard University, and an honorary doctorate from the University of Lille, France.